Expansion and cytotoxicity of mucosal CAR + T cells in enterocolitis associated with BCMA CAR-T cell therapy.

Ciltacabtagene autoleucel (cilta-cel) is a B cell maturation-antigen-targeting chimeric antigen receptor (CAR) T cell product approved for relapsed/refractory multiple myeloma treatment. Previously reported cases of post-cilta-cel immune effector cell enterocolitis (IEC-EC) have been described as a severe diarrhea associated with clonal CAR T cell populations. Here we report nine cases of cilta-cel-associated IEC-EC with CAR T cell-positive (CAR + ) infiltration in 158 cilta-cel-treated patients
Ciltacabtagene autoleucel (cilta-cel) is a B cell maturation-antigen-targeting chimeric antigen receptor (CAR) T cell product approved for relapsed/refractory multiple myeloma treatment. Previously reported cases of post-cilta-cel immune effector cell enterocolitis (IEC-EC) have been described as a severe diarrhea associated with clonal CAR T cell populations. Here we report nine cases of cilta-cel-associated IEC-EC with CAR T cell-positive (CAR + ) infiltration in 158 cilta-cel-treated patients at MD Anderson Cancer Center (incidence of 5.1% at a 6-month landmark and 5.7% globally). Cilta-cel infiltration was the primary cause of IEC-EC, and all cases demonstrated monoclonal or oligoclonal T cell populations as measured by vector integration analysis, flow cytometry and T cell receptor sequencing. Patients with IEC-EC had 100-fold more CAR T cell persistence in the peripheral blood than patients without IEC-EC. RNA sequencing analysis revealed increased cytotoxic and inflammatory programs associated with the CAR + infiltrates relative to controls. Clonal vector integration occurred in introns of highly expressed genes without evidence of vector-mediated mutagenesis. Candidate driver mutations were sparse and heterogeneous, distinguishing IEC-EC from peripheral T cell lymphoma following CAR T cell therapy. In sum, we find that IEC-EC pathology represents a distinct, duodenum-predominant, clonal lymphoproliferative disorder characterized by the infiltration of clonal CAR + cytotoxic T cells into the gastrointestinal tract.




